Experiment 825015
Compounds isolated
Alerts
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV INFUSION |
| Organism | Empty organism |
| Citation | TRUMP,DL: LOPRINZI,CL:. (1984). PHASE II TRIAL OF ETOPOSIDE IN ADVANCED PROSTATE CANCER.. 68(9) |
| Amount utilized | |
| Compound isolated | |
| Disease | IN THIS PHASE II TRIAL OF 21 PATIENTS WITH METASTATIC PROSTATE CANCER AND SYMPTOMATIC ADVANCED DISEASE, THE DRUG WAS ADMINISTERED BY CONTINOUS INFUSION EVERY 28 DAYS. THERE WERE NO DISEASE REGRESSIONS, THE MEDIAN TIME TO DISEASE PROGRESSION AFTER ETOPOSIDE WAS 31-141 DAYS (MEDIAN 63). SIDE EFFECTS WERE MILD WITH ALOPECIA, AND EASILY MANAGED GASTROINTESTINAL UPSET. |
| Dose amount | 50.0 MG |
| Number | 1 |
| Qualitative result | INACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |